AstraZeneca PLC on Monday reported positive results from a test of danicopan for the treatment of paroxysmal nocturnal haemoglobinuria, or PNH, a rare and severe blood disorder.
The pharmaceutical.
AstraZeneca will present new clinical and real-world data in several hematological conditions at the 65th Annual Meeting of the American Society of Hematology in San Diego, California, December.
AstraZeneca Bolsters Haematology Expertise at ASH 2023 miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
AstraZeneca advances scientific leadership in haematology at ASH 2023 nationaltribune.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nationaltribune.com.au Daily Mail and Mail on Sunday newspapers.